The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

A study assessing the use of continuous glucose monitoring in patients with T1D shows significant reductions in A1c and diabetes distress, with or without a behavioral intervention.

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the American Diabetes Association Scientific ...

Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...

The original Hermès Birkin once owned by Jane Birkin is headlining the Sotheby’s Fashion Icons auction in Paris. We unravel ...

Notable research news last week included Sarepta Therapeutics reporting another death associated with a trial of its Duchenne ...

Global Functional Dyspepsia Drug Market is valued approximately at USD 10.52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.92% over the forecast period 2024-2032 ...

The Global Monoclonal Antibody Therapeutics Market is valued at approximately USD 205.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 15.0% over the forecast ...